Content
02/19/2025
S. San Francisco, CA USA
Perceive Biotherapeutics
completed $15 million Series A Round funding. Investors include
Braidwell, Catalio Capital Management, Deerfield Management Company, Google Ventures, Johnson & Johnson Innovation, Retinal Degeneration Fund.
About
Perceive Pharma is advancing novel small molecule neuroprotective therapeutics, with lead pipeline programs in glaucoma and other ophthalmic diseases. Perceive was founded on compelling research that leveraged a comprehensive screening process in retina cells to identify maximally neuroprotective biological pathways.
Startup
Sector:
Biotech
Life Science
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
